ArticleACS applied materials & interfaces2025
Real-Time Optical and Acoustic Characterization of Phase-Shift Droplets for Drug-Delivery Applications.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-time drug release monitoring from acoustically responsive scaffolds.Ultrasonics sonochemistry · 2026Article
- Energy Conservation and Production Efficiency Enhancement in Herbal Medicine Extraction: Self-Adaptive Decision-Making Boiling Judgment via Acoustic Emission Technology.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Phase-shift droplets undergoing acoustic droplet vaporization (ADV) offer a promising approach for ultrasound-mediated drug delivery, enabling the spatiotemporally controlled release of therapeutic payloads. A comprehensive understanding of their behavior, through both optical and acoustic methods, is essential for optimizing the therapeutic efficacy. In this study, we investigated the effects of driving pressure, pulse duration, and bulk boiling point of perfluorocarbon droplets on ADV dynamics, payload release, and acoustic emissions. We employed ultra-high-speed brightfield [10 million frames per second (Mfps)], fluorescence (2 Mfps), and confocal microscopy (1 fps) to capture ADV and real-time payload release in fibrin-based hydrogels. During ADV, payload release velocities reached 2-4 m/s, slowing to 0.6-2.7 μm/s post ultrasound. While the cycle number and pressure affected early bubble expansion and acoustic output, long-term bubble behavior and release kinetics were governed by the droplet's thermophysical properties. Ultra-high-speed imaging revealed a direct coupling between bubble dynamics and payload release during ultrasound exposure, with release continuing via diffusion after ultrasound. Notably, payload release rates post-ultrasound exceeded bubble growth rates. Additionally, acoustic emissions, recorded via passive cavitation detection, increased with both pressure and pulse number but decreased in droplets with higher bulk boiling points. These findings underscore the importance of integrating multimodal imaging methods to elucidate ADV mechanisms and design effective hydrogel-based drug-delivery systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.